Buy Cipla, Aurobindo Pharma: CA Rudramurthy of Vachana Investments is of the view that one can buy Cipla and Aurobindo Pharma.
If I look specifically pharma as a sector and even IT, because of the rupee falling down along with the Chinese Yuan, I see definitely IT and pharma to slightly outperform the market. However, as the overall market is very weak, I just see a slight outperformance from these two sectors but I don’t see a spectacular rise from current level."
"One can look at stocks like Cipla and Aurobindo Pharma which looks very interesting both for investment as well as for short-term trading. Aurobindo Pharma has been doing pretty well and even Cipla at levels of around Rs 650-670 makes a sensible buy along with Aurobindo Pharma. However, midcap pharma also looks good for an investment of two-three year timeframe," he said.
Read more at: http://www.moneycontrol.com/news/stocks-views/buy-cipla-aurobindo-pharma-ca-rudramurthy_2671761.html?utm_source=ref_article
Bullish on market and Bank Nifty for August: Vachana:
Market is strong and might take a pause and consolidate, says CA Rudramurthy BV of Vachana Investments, adding, it would take some time for it to come in the range of 8550-8650.
Though RBI’s decision dampened market sentiment, Vachana Investments is bullish on the market. Market is strong and might take a pause and consolidate, says CA Rudramurthy BV of Vachana Investments, adding, it would take some time for it to come in the range of 8550-8650.
Read more at: http://www.moneycontrol.com/news/market-outlook/bullishmarketbank-nifty-for-august-vachana_2321781.html?utm_source=ref_article
If I look specifically
pharma as a sector and even IT, because of the rupee falling down along
with the Chinese Yuan, I see definitely IT and pharma to slightly
outperform the market. However, as the overall market is very weak, I
just see a slight outperformance from these two sectors but I don’t see a
spectacular rise from current level."
Read more at: http://www.moneycontrol.com/news/stocks-views/buy-cipla-aurobindo-pharma-ca-rudramurthy_2671761.html?utm_source=ref_article
Read more at: http://www.moneycontrol.com/news/stocks-views/buy-cipla-aurobindo-pharma-ca-rudramurthy_2671761.html?utm_source=ref_article
If I look specifically pharma as a sector and even IT, because of the rupee falling down along with the Chinese Yuan, I see definitely IT and pharma to slightly outperform the market. However, as the overall market is very weak, I just see a slight outperformance from these two sectors but I don’t see a spectacular rise from current level."
"One can look at stocks like Cipla and Aurobindo Pharma which looks very interesting both for investment as well as for short-term trading. Aurobindo Pharma has been doing pretty well and even Cipla at levels of around Rs 650-670 makes a sensible buy along with Aurobindo Pharma. However, midcap pharma also looks good for an investment of two-three year timeframe," he said.
Read more at: http://www.moneycontrol.com/news/stocks-views/buy-cipla-aurobindo-pharma-ca-rudramurthy_2671761.html?utm_source=ref_article
Bullish on market and Bank Nifty for August: Vachana:
Market is strong and might take a pause and consolidate, says CA Rudramurthy BV of Vachana Investments, adding, it would take some time for it to come in the range of 8550-8650.
Though RBI’s decision dampened market sentiment, Vachana Investments is bullish on the market. Market is strong and might take a pause and consolidate, says CA Rudramurthy BV of Vachana Investments, adding, it would take some time for it to come in the range of 8550-8650.
Read more at: http://www.moneycontrol.com/news/market-outlook/bullishmarketbank-nifty-for-august-vachana_2321781.html?utm_source=ref_article
Buy Cipla, Aurobindo Pharma: CA Rudramurthy
CA Rudramurthy of Vachana Investments is of the view that one can buy Cipla and Aurobindo Pharma.
Read more at: http://www.moneycontrol.com/news/stocks-views/buy-cipla-aurobindo-pharma-ca-rudramurthy_2671761.html?utm_source=ref_article
Read more at: http://www.moneycontrol.com/news/stocks-views/buy-cipla-aurobindo-pharma-ca-rudramurthy_2671761.html?utm_source=ref_article
